Guidance

NICE no longer plans to develop guidance on Freelite assays for diagnosing multiple myeloma and related conditions in primary care. We will review this decision if a stakeholder notifies NICE again of the topic.

Guidance development process

How we develop NICE diagnostics guidance

  • National Institute for Health and Care Excellence (NICE)